Gene and Cell Therapy – Multimedia

This video aims to address frequently questions, hopes and concerns that patients and caregivers, across many different diseases, have about gene therapy.

In this episode, we discuss the potential of personalized, precision approaches to change healthcare. We hear how cancer care has been one of the first areas to take advantage of patient-specific data, the risks and rewards of increased access to genomic data and how neuroscience is beginning to explore diseases of the brain at a personal level.

This instalment of Teach Me in 10 features Dr Theo Roth, whose work bridges a number of different fields, such as genome engineering, cancer immunology and cell-based therapies.

In this guide, learn how to develop creative assay solutions to vital questions in your therapeutic research project.

There have been many exciting developments in the biopharma research field this year. Here, we revisit the top 10 most-read news stories of 2019 at Technology Networks.

We've seen some exciting research developments take place in the genomics field throughout 2019. In this list, we revisit the top 10 most-read news stories, published on Technology Networks.

This listicle explores the five different types of immunotherapy, how each type works, and takes a closer look at some examples of approved immunotherapies.

Hemophilia is a genetic disease that prevents blood from clotting properly leading to prolonged internal and external bleeding. There are existing treatments for hemophilia that require lifelong administration, while gene therapy may offer a one-time treatment to address the cause of the disease.

In a talk about a breakthrough, CAR T-cell therapy pioneer, Carl June shares how three decades of research culminated in a therapy that's eradicated cases of leukemia once thought to be incurable – and explains how it could be used to fight other types of cancer.

Researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.